Probable 4‐Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG‐PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome
Movement Disorders Clinical Practice · 2024
DOI: 10.1002/mdc3.13959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2024. Verfasst von Jacy Bezerra Parmera und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil. Hauptthemen laut MEDLINE: Corticobasal Degeneration, Tauopathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Background
Corticobasal syndrome (CBS) is associated with diverse underlying pathologies, including the four‐repeat (4R)‐tauopathies. The Movement Disorders Society (MDS) criteria for progressive supranuclear palsy (PSP) proposed the novel category “probable 4R‐tauopathy” to address the phenotypic overlap between PSP and corticobasal degeneration (CBD).
Objectives
To investigate the clinical ability of the MDS‐PSP criteria for probable 4R‐tauopathy in predicting a negative amyloid‐PET in CBS. Additionally, this study aims to explore CBS patients classified as 4R‐tauopathy concerning their clinical features and neuroimaging degeneration patterns.
Methods
Thirty‐two patients with probable CBS were prospectively evaluated and split into those who fulfilled or did not fulfill the 4R‐tauopathy criteria (CBS‐4RT+ vs. CBS‐4RT−). All patients underwent positron emission tomographies (PET) with [ 18 F]fluorodeoxyglucose and [ 11 C]Pittsburgh Compound‐B (PIB) on a hybrid PET‐MRI scanner to perform multimodal quantitative comparisons with a control group.
Results
Eleven patients were clinically classified as CBS‐4RT+, and only one had a positive PIB‐PET. The CBS‐4RT+ classification had 92% specificity, 52% sensitivity, and 69% accuracy in predicting a negative PIB‐PET. The CBS‐4RT+ group presented with dysarthria and perseveration more often than the CBS‐4RT− group. Moreover, the CBS‐4RT+ group showed a prominent frontal hypometabolism extending to the supplementary motor area and striatum, and brain atrophy at the anterior cingulate and bilateral striata.
Conclusions
The 4R‐tauopathy criteria were highly specific in predicting a negative amyloid‐PET in CBS. Patients classified as 4R‐tauopathy presented distinct clinical aspects, as well as brain metabolism and atrophy patterns previously associated with tauopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.
- Laboratory of Nuclear Medicine (LIM 43), Nuclear Medicine Division and Institute of Radiology, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.
- Department of Physical Therapy, Speech, and Occupational Therapy, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.
ORCID-Profile: Jacy Bezerra Parmera, Marcos Castello Barbosa de Oliveira
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Parmera, J. B., de Godoi Carneiro, C., de Almeida, I. J., de Oliveira, M. C. B., Barbosa, P. M., Studart-Neto, A., Ono, C. R., Nitrini, R., Buchpiguel, C. A., Barbosa, E. R., Brucki, S. M. D., & Coutinho, A. M. (2024). Probable 4‐Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG‐PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13959
Vancouver
Parmera JB, de Godoi Carneiro C, de Almeida IJ, de Oliveira MCB, Barbosa PM, Studart-Neto A, et al. Probable 4‐Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG‐PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome. Movement Disorders Clinical Practice. 2024. doi:10.1002/mdc3.13959
BibTeX
@article{Parmera2024,
author = {Parmera, Jacy Bezerra and de Godoi Carneiro, Camila and de Almeida, Isabel Junqueira and de Oliveira, Marcos Castello Barbosa and Barbosa, Pedro Melo and Studart-Neto, Adalberto and Ono, Carla Rachel and Nitrini, Ricardo and Buchpiguel, Carlos Alberto and Barbosa, Egberto Reis and Brucki, Sonia Maria Dozzi and Coutinho, Artur Martins},
title = {Probable 4‐Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG‐PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome},
journal = {Movement Disorders Clinical Practice},
year = {2024},
doi = {10.1002/mdc3.13959}
}
EUVIMED